Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

AgeX Therapeutics Inc. (AGE)

0.9001   0.02 (2.28%) 07-07 16:00
Open: 0.88 Pre. Close: 0.88
High: 0.9179 Low: 0.88
Volume: 70,188 Market Cap: 34M
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as the ischemic heart. Its lead drug-based therapeutic candidate in discovery is AGEX-iTR1547, a drug-based formulation to restore regenerative potential in a range of aged tissues afflicted with degenerative diseases. In addition, the company markets human embryonic stem cells; and GeneCards Database Suite, including genomic interpretation algorithms and analysis tools for use by researchers at pharmaceutical and biotechnology companies, and other institutions. AgeX Therapeutics, Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.911 - 0.917 0.917 - 0.922
Low: 0.878 - 0.885 0.885 - 0.89
Close: 0.891 - 0.902 0.902 - 0.91

Technical analysis

as of: 2020-07-07 4:31:22 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.25     One year: 1.50
Support: Support1: 0.74    Support2: 0.61
Resistance: Resistance1: 1.07    Resistance2: 1.28
Pivot: 0.89
Moving Average: MA(5): 0.90     MA(20): 0.88
MA(100): 0.92     MA(250): 1.55
MACD: MACD(12,26): 0.01     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 37.87     %D(3): 39.95
RSI: RSI(14): 51.67
52-week: High: 3.36  Low: 0.67  Change(%): -71.9
Average Vol(K): 3-Month: 39445  10-Days: 42752

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
AGE has closed below upper band by 45.5%. Bollinger Bands are 34.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 06 Jul 2020
Stocks To Trade: AgeX Therapeutics, Inc. (AGE) Attracting Wallstreet Traders - Invest Million

Mon, 29 Jun 2020
Will AgeX Therapeutics, Inc. (AGE) Remain Competitive? - The News Heater

Tue, 16 Jun 2020
AgeX Therapeutics Inc. (AGE), Pluristyx Announce Pact to Expand Access to Clinical-Grade Human Pluripotent Stem Cells for Therapeutic Applications -

Fri, 05 Jun 2020
AgeX Therapeutics Receives Stock Exchange Deficiency Letter - Business Wire

Fri, 29 May 2020
AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A - Business Wire

Thu, 21 May 2020
AgeX Therapeutics, Inc. Appoints Andrea Park as Chief Financial Officer - Business Wire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38
Shares Float (M) 32
% Held by Insiders 44.02
% Held by Institutions 24.58
Shares Short (K) 2,130
Shares Short P. Month (K) 1,490

Stock Financials

EPS -0.324
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.020
Profit Margin
Operating Margin -680.97
Return on Assets (ttm) -90.7
Return on Equity (ttm) -256.8
Qtrly Rev. Growth 32.7
Gross Profit (p.s.) 0.039
Sales Per Share 0.049
EBITDA (p.s.) -0.315
Qtrly Earnings Growth
Operating Cash Flow (M) -10
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -2.78
PEG Ratio
Price to Book value -45.01
Price to Sales 18.32
Price to Cash Flow -3.53

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.